Somite.ai is a venture-backed company aiming to become the OpenAI of stem cell biology, developing AI foundation models to produce human tissue for cell therapies at scale for diseases such as diabetes, obesity, and muscular dystrophies. Somite's AI platform, AlphaStem, fuels a virtuous cycle: It enables new cell therapies, generating massive data that further improve the platform, empowering even faster therapy creation with broader applications.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/16/24 | $5,300,000 | Pre-Seed |
Lerer Hippeau Ventures Next Coast Ventures TechAviv Founder Partners  Texas Venture Partners Trust Ventures | undisclosed |
